4.5 Article

Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease

A. Barre et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Review Biochemistry & Molecular Biology

Can We Predict the Efficacy of Anti-TNF-alpha Agents?

Loris Riccardo Lopetuso et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Medicine, General & Internal

Crohn's disease

Daniel C. Baumgart et al.

LANCET (2012)

Article Gastroenterology & Hepatology

Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity

Severine Vermeire et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Review: Anti-adhesion molecule therapy for inflammatory bowel disease

Subrata Ghosh et al.

Therapeutic Advances in Gastroenterology (2010)

Article Pharmacology & Pharmacy

Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody

N. Pullen et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Article Gastroenterology & Hepatology

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials

Laurent Peyrin-Biroulet et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Clinical Neurology

Immune surveillance in multiple sclerosis patients treated with natalizumab

O Stüve et al.

ANNALS OF NEUROLOGY (2006)